Exclusive

Delic Looks to Build a Sprawling ‘Psychedelic Ecosystem’

There have been a number of high profile initial public offerings in the psychedelic space, including COMPASS Pathways’ (NASDAQ: CMPS) $2 billion debut. While there are now more than 30 publicly traded companies in the space, there are thousands more private companies at various stages of funding and development.  Delic Corp. (CSE: DELC) (OTCQB: DELCF) […]

MagicMed: Bringing the Drug Candidate Library Model to Psychedelics

The psychedelics market is often described as “emerging”, “burgeoning”, and other similar words, and while certainly true to a large extent, investors shouldn’t think for a moment this is all new. It’s far from it. There are scores of clinical and preclinical data to leverage, most collected before the Controlled Substance Act was enacted in […]

How to Invest in Cannabis Delivery

Delivery services of all kinds experienced record-breaking growth in 2020 thanks to a global pandemic that has depressed retailers, restaurants, and grocery stores. Of course, these trends are just an acceleration of an existing transition from brick-and-mortar to e-commerce—a trend that many in the cannabis industry are betting will be transformative. Let’s take a look […]

CBD Innovator, HempFusion, Makes Successful Debut on TSX

  HempFusion Wellness Inc. (TSX: CBD-U) shares soared over 65% following their successful debut on the Toronto Stock Exchange (TSX) on Wednesday, January 6, 2021. Cannabidiol, or CBD, has become one of the most popular health and wellness products in the world over the past couple of years. According to Research and Markets, the global […]

HempFusion (TSX:CBD.U): New Listing on the Toronto Stock Exchange

CBD sales are projected to reach $16.8 billion by 2025, according to Brightfield Group, but the market remains extremely fragmented. With a glut of non-differentiated and low-quality products, regulators are poised to introduce new rules governing the market as consumers increasingly seek out the highest quality options that they can trust. Let’s take a look […]

Christina Lake Cannabis Unlocks Value via Extraction

Many licensed producers have launched value flower brands at competitive prices to grow revenue. While Christina Lake Cannabis Corp. (CSE: CLC) produces some of the industry’s lowest cost cannabis flower, the company intends to leverage its low-cost inputs into high margin extracts to create Cannabis 2.0 products.   Let’s take a closer look at the company’s […]

MagicMed zielt mit dem Programm für pharmazeutische Derivate auf einen massiven Markt ab

Der Markt für Psychedelika ist aufgrund des unentdeckten therapeutischen Potenzials psychedelischer Moleküle schwer zu berechnen. Die wissenschaftliche Gemeinschaft hat gezeigt, dass Psychedelika mehrere Milliarden-Dollar-Märkte im Bereich Gehirn und psychische Gesundheit behandeln können. MagicMed Industries zielt darauf ab, Teile beider Märkte zu erobern, indem es ein einzigartiges, patentgeschütztes Portfolio an geistigem Eigentum entwickelt, das mehrere Medikamentenkandidaten, […]

MagicMed Targets Massive Market with Pharmaceutical Derivatives Program

The psychedelics market is hard to calculate because of the undiscovered therapeutic potential of psychedelic molecules. The scientific community has shown that psychedelics could treat multiple multibillion-dollar markets in the brain and mental health space. MagicMed Industries positions itself to capture portions of each market by developing a unique, patent-protected intellectual property portfolio that safeguards […]

Tryp Debuts on the Canadian Securities Exchange

  Tryp Therapeutics Inc. (CSE: TRYP) began trading on the Canadian Securities Exchange (CSE) on December 18, 2020 under the ticker symbol “TRYP”. “Trading on the CSE is a significant milestone in Tryp’s mission to transform the treatment of neuropsychiatric diseases with safe and effective psychedelic medicine,” said CEO James Kuo, MD. “All of the […]

Psychedelics Production Challenges & Solutions

Psilocybin and other tryptamine-based compounds could become blockbuster therapeutics for the treatment of depression, post-traumatic stress disorder and other difficult to treat psychiatric conditions. While many clinical trials are underway, researchers are turning their attention toward the problem of mass-producing psychedelics in a cost-effective way. Let’s take a look at some of the production challenges […]

Christina Lake Cannabis Expands Production After Bumper Harvest

The cannabis industry experienced strong growth throughout the COVID-19 pandemic as people spend more time at home. According to Statistics Canada, sales between April and June were 74% higher than the same period a year ago. These trends have continued into the third quarter as Canadians increasingly move away from black market dealers. Christina Lake […]

Innovation zahlt sich aus bei Psychedelika

Es besteht ein erhebliches Interesse am psychedelischen Bereich und an den vielversprechenden psychedelischen Molekülen für die Behandlung von psychischen Erkrankungen. Geisteskrankheiten sind eine allgegenwärtige menschliche Erfahrung und eine bisher nur unzureichend behandelte medizinische Notwendigkeit. Psychedelika bieten eine Alternative zu unwirksamen Behandlungen, da sie über andere Wirkmechanismen funktionieren. Psychedelische Arzneimittel müssen jedoch verbessert werden, um aus […]

HempFusion Prepares to Go Public as a Unique Play on CBD

Charlotte’s Web Holdings Inc. (TSX: CWEB) bought Abacus Health Products Inc. in a stock transaction worth about $100 million last June. With competition on the rise in the CBD industry, Abacus provided Charlotte’s Web with a portfolio of over-the-counter (OTC) topical products that combined active pharmaceutical ingredients with hemp extracts. HempFusion Inc. (TSX: CBD.U – […]

Innovation Pays Off in Psychedelics

There has been significant interest in the psychedelic space and of the promise psychedelic molecules show in treating mental health conditions. Mental illness is a ubiquitous human experience and an insufficiently addressed medical necessity. Psychedelics offer an alternative to ineffective treatments by acting via a different mechanism of action. However, psychedelic pharmaceuticals need improvement to […]

Just How Large is the Psychedelics Market?

The psychedelics industry may appear to have suddenly emerged as one of the hottest corners of the stock market, but researchers have been working for decades to show the efficacy of these treatments and regulators are just starting to appreciate the possibilities. Investors could see strong growth in the industry as companies commercialize breakthrough therapeutics […]

How to Position Your Cannabis Portfolio for a Biden Presidency

The House of Representatives cast a historic vote to end the nationwide prohibition on cannabis on December 4, 2020. While the MORE Act would remove cannabis from the Controlled Substances Act and decriminalize the drug across the country, the legislation will almost certainly fail to pass the Republican-controlled Senate. While decriminalization won’t happen this year, […]

HempFusion Gears Up for IPO on the TSX

HempFusion Wellness Inc., a leading health and wellness CBD company, recently closed the order book for its proposed initial public offering (IPO), marking another step closer to becoming a publicly-traded company on the Toronto Stock Exchange (TSX) over the coming months. Completion of this proposed initial public offering has the potential to accelerate the company’s […]

Pure Extracts Unveils Plans for Functional Mushrooms

  There are more than 2,000 species of edible fungi and at least 15 have functional benefits that support overall health. Like other superfoods, functional mushrooms have antioxidant properties that support the immune system, dietary fiber to aid in healthy digestion and numerous other benefits to everything from mental clarity to skin health. At the […]

Why Focus on Cannabis & Mushroom Extracts?

  Cannabis extracts are poised to become a $28.5 billion market by 2027, according to Grand View Market Research, representing a 16.6% compound annual growth rate. At the same time, the functional mushroom market is forecast to reach $34.3 billion by 2024, which represents a respectable 8% compound annual growth rate. Let’s take a look […]

ManifestSeven: The Importance of Cannabis Distribution

  Most cannabis investors are familiar with cultivation operations and dispensaries, but distribution is quickly becoming one of the industry’s most important components. Although distribution plays a big role in other regulated industries, the cannabis industry has only begun recently to recognize the critical role of distributors in the ecosystem. Let’s take a look at […]

Edible Manufacturing a Key to Cannabis Market Growth

It’s been about a year since Canada, following up on the national legalization of adult-use cannabis, allowed ingestible (edible and drinkable) products on the market. It took a few months for some products to hit the shelves and find traction, but both supply and demand have been trending upward lately. According to market research firm […]

CBD Makes Its Way into Mainstream Retail

The U.S. market for CBD products is projected to reach $23.7 billion by 2023, according to Brightfield Group, representing a seven-fold increase in the market’s size. While it’s one of the fastest-growing subsets of the multi-trillion-dollar wellness industry, CBD products remain absent from most mass-market retailers. CVS became the first large-scale retailer to offer CBD […]

How to Invest in the Rise of Cannabis-Infused Beverages

The cannabis industry has rapidly transitioned from an obscure counterculture movement to a legal industry that could exceed $27 billion by 2024, according to the MJBiz Daily. In addition to a growing number of states legalizing cannabis, the industry has evolved to provide a growing array of different products, including tinctures, topicals, edibles—and beverages.    Let’s […]

Pure Extracts: Recurring Revenue with Blue Sky Potential

The global cannabis extract market is projected to reach $28.5 billion by 2027, according to Grand View Research, representing a 16.6% compound annual growth rate. In addition to the relatively mature cannabis market, the wider market for plant-based extracts could see tremendous growth from the functional mushroom revolution. Let’s take a look at how Pure […]

California Cannabis Industry to Hit $6 Billion by 2025

California’s cannabis industry is on track to surpass $6 billion in 2025, according to BDS Analytics, which would represent a sixth of legal cannabis sales in the United States. Although Nevada and a handful of other states experienced COVID-19-related disruptions, California’s mature market has managed to weather the pandemic thus far. Let’s take a closer […]

Cybin Goes Public on the NEO Exchange

  The direct and indirect costs of mental health disorders add up to more than $2.5 trillion worldwide, according to the National Centre for Biotechnology Information. A growing body of research suggests that psychedelics could play a major role in the treatment of these disorders. Not surprisingly, a psychedelics industry has emerged with a number […]

CB Therapeutics: Producing Rare Cannabinoid & Psychedelic Molecules at Scale

The cannabis industry has evolved from the legalization of dried cannabis to an increasingly detailed understanding of individual cannabinoids. While THC and CBD are the two most common, researchers are increasingly interested in CBC, THCV and other rare cannabinoids that could have specific and desirable effects on certain medical indications. The problem is that these […]

Growers vs. Extractors: Where to Invest in Cannabis

Canopy Growth Corp., Tilray Inc. and Aurora Cannabis Inc. are the largest cannabis cultivators in the world, but the shift in consumer preferences from flower to extracts has made cannabis extraction the fastest growing subset of the industry. In fact, MediPharm Labs Corp. and The Valens Company reported revenue of nearly C$14 million  and about […]

MagicMed verkürzt die Fristen für die Kommerzialisierung durch Universitätsvertrag

Die meisten Pharma- und Biotech-Investoren sind mit langen Kommerzialisierungsfristen vertraut, aber es gibt einige Möglichkeiten, diese zu verkürzen. Beispielsweise bietet die Food and Drug Administration für bestimmte Therapien, die auf lebensbedrohliche Erkrankungen abzielen, Bezeichnungen wie Fast Track, Durchbruchstherapie, beschleunigte Zulassung und Prioritätsprüfung an. MagicMed Industries Inc., ein Entwickler von lizenzierbaren psychedelischen molekularen Derivaten, verkürzte seinen […]

HempFusion: A Health and Wellness Leader to IPO on the TSX Senior Board

Cannabidiol, better known as CBD, has become one of the fastest growing segments of the health and wellness industry. According to BDS Analytics and ArcView, CBD sales will grow at a 49% compound annual growth rate to exceed $20 billion by 2024.  There are very few companies in the sector have the quality, scale and […]